Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer

MLA

Roperch, J. P., et al. Aberrant Methylation of NPY, PENK, and WIF1 as a Promising Marker for Blood-Based Diagnosis of Colorectal Cancer. 2013. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.ocn906694489&authtype=sso&custid=ns315887.

APA

Roperch, J.-P., Incitti, R., Forbin, S., Bard, F., Mansour, H., Mesli, F., Baumgaertner, I., Brunetti, F., & Sobhani, I. (2013). Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer.

Chicago

Roperch, J.-P., R. Incitti, S. Forbin, F. Bard, H. Mansour, F. Mesli, I. Baumgaertner, F. Brunetti, and I. Sobhani. 2013. “Aberrant Methylation of NPY, PENK, and WIF1 as a Promising Marker for Blood-Based Diagnosis of Colorectal Cancer.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.ocn906694489&authtype=sso&custid=ns315887.